Business Description
Clene Inc
NAICS : 541714
SIC : 2834
ISIN : US1856341029
Share Class Description:
FRA:84C: Ordinary SharesDescription
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.09 | |||||
| Equity-to-Asset | 0.26 | |||||
| Debt-to-Equity | 2.4 | |||||
| Debt-to-EBITDA | -0.74 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -8.34 | |||||
| Beneish M-Score | -3.78 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -20.6 | |||||
| 3-Year EBITDA Growth Rate | 24.8 | |||||
| 3-Year EPS without NRI Growth Rate | 19.1 | |||||
| 3-Year FCF Growth Rate | 35.9 | |||||
| 3-Year Book Growth Rate | 158.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.16 | |||||
| 9-Day RSI | 36.69 | |||||
| 14-Day RSI | 38.72 | |||||
| 6-1 Month Momentum % | -19.58 | |||||
| 12-1 Month Momentum % | -56.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.53 | |||||
| Quick Ratio | 1.53 | |||||
| Cash Ratio | 1.38 | |||||
| Days Inventory | 195.47 | |||||
| Days Sales Outstanding | 69.2 | |||||
| Days Payable | 4742.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -29.2 | |||||
| Shareholder Yield % | -108.31 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 81.5 | |||||
| Operating Margin % | -5850.15 | |||||
| Net Margin % | -7569.42 | |||||
| FCF Margin % | -4679.17 | |||||
| ROE % | -427.21 | |||||
| ROA % | -93.4 | |||||
| ROIC % | -146.74 | |||||
| ROC (Joel Greenblatt) % | -312.02 | |||||
| ROCE % | -119.58 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 55.5 | |||||
| PB Ratio | 3.2 | |||||
| Price-to-Tangible-Book | 3.31 | |||||
| EV-to-EBIT | -0.9 | |||||
| EV-to-Forward-EBIT | -0.89 | |||||
| EV-to-EBITDA | -0.93 | |||||
| EV-to-Forward-EBITDA | -0.99 | |||||
| EV-to-Revenue | 61.49 | |||||
| EV-to-Forward-Revenue | 61.43 | |||||
| EV-to-FCF | -1.31 | |||||
| Earnings Yield (Greenblatt) % | -111.56 | |||||
| FCF Yield % | -70.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Clene Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.605 | ||
| EPS (TTM) (€) | -0.482 | ||
| Beta | -0.28 | ||
| Volatility % | 116.42 | ||
| 14-Day RSI | 38.72 | ||
| 14-Day ATR (€) | 0.024591 | ||
| 20-Day SMA (€) | 0.3382 | ||
| 12-1 Month Momentum % | -56.63 | ||
| 52-Week Range (€) | 0.228 - 0.995 | ||
| Shares Outstanding (Mil) | 128.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Clene Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Clene Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Clene Inc Frequently Asked Questions
What is Clene Inc(FRA:84C)'s stock price today?
The current price of FRA:84C is €0.30. The 52 week high of FRA:84C is €1.00 and 52 week low is €0.23.
When is next earnings date of Clene Inc(FRA:84C)?
The next earnings date of Clene Inc(FRA:84C) is 2024-05-10 Est..
Does Clene Inc(FRA:84C) pay dividends? If so, how much?
Clene Inc(FRA:84C) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers